Recruiting studies: Metastatic Castration Sensitive Prostate Cancer Mcspc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · 341 location(s) · Pfizer · NCT07028853 Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
NA · 1 location(s) · Paul Viscuse · NCT06429813 A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Phase 1 · 25 location(s) · Astellas Pharma Global Development, Inc. · NCT04729114 A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Trea
Phase 3 · 2 location(s) · ORIC Pharmaceuticals · NCT07723248

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.